Press Release | NeoGenomics Laboratories

May 15, 2017

NeoGenomics Reports that its NeoLAB® Liquid Biopsy Prostate Test is More Accurate than Conventional Biopsies in Predicting High Grade Prostate Cancer

April 26, 2017

NeoGenomics Reports 15% Volume Growth and 10% Reduction in Average Cost per Test in the First Quarter of 2017

April 20, 2017

NeoGenomics Appoints Bill Bonello as Vice President, Treasurer, and Director of Corporate Development

April 14, 2017

NeoGenomics Schedules its Q1 2017 Earnings Release for April 26, 2017

March 13, 2017

NeoGenomics and Definiens Enter Into Agreement to Develop Novel Assays for Clinical Trials & Clinical Testing

February 22, 2017

NeoGenomics Reports 122% Revenue Growth to $60.5 Million and 11% Reduction in Average Cost per Test in the Fourth Quarter of 2016

February 8, 2017

NeoGenomics Schedules its Q4 and Full Year 2016 Earnings Release for February 22, 2017

December 22, 2016

NeoGenomics Closes $150 Million Senior Credit Facility

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients